VPC32183 is a competitive antagonist at the LPA1 and LPA3 receptors. VPC32183 is devoid of agonist activity at the human LPA1, LPA2 and LPA3 receptors, and, presumably, at other mammalian LPA receptors. References: Violet PC, Billon-Denis E, Robin P. Inhibition of lipid phosphate phosphatase activity by VPC32183 suppresses the ability of diacylglycerol pyrophosphate to activate ERK(1/2) MAP kinases. Biochim Biophys Acta. 2012 Nov;1821(11):1394-405. doi: 10.1016/j.bbalip.2012.07.009. Epub 2012 Jul 20. PubMed PMID: 22820196.

纯度：≥98%

CAS：717110-61-7